Filter posts

Tekmira CEO Discusses Ebola Therapy Development at 2014 BIO Investor Forum

Today at the 13th Annual BIO Investor Forum, Tekmira CEO Dr. Mark Murray participated in a …

T-Cell Therapies: Best Bets in Pushing Down the Cost Curve and Prioritizing Cancer Targets

New approaches in cancer immunology are achieving promising early-stage results through novel techniques for arming …

Gates Foundation and Grand Challenge Partners Announce New Investments in Breakthrough Science

At an event in Seattle today, the Bill & Melinda Gates Foundation and a group …

New PhRMA report: Nearly 800 Cancer Medicines in Development

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) shows that biopharma …

Washington Post: Why Extremely Expensive Drugs Are Often Worth the Cost

Jason Millman highlights a new study published in Health Affairs showing specialty drugs often provide …

Health Affairs: 5 Myths about Cancer Care in America

In the latest issue of Health Affairs, Dana Goldman of the University of Southern California …

Cancer drugs save and extend lives

This week, CBS aired a misleading segment on the cost of innovative cancer therapies. BIO …

5 Priorities for Reducing Infant Mortality

In the U.S., the number of babies who die in their first year of life …

New Treatments Needed for Obesity

ObesityWeek 2014, Nov. 2-7, in Boston Offers Opportunities to Learn & Connect Coauthored by The …

Patient and Venture Philanthropy Groups Presenting at 2014 BIO Investor Forum

BIO’s alliance development team works to foster collaboration between the biotech industry and nonprofit disease …